Nuevocor

Singapore, Singapore

Nuevocor operates as a preclinical-stage biotech company.

$45.0M raised

May 2025

Series B

Top Investors

Highlight CapitalKurma PartnersBoehringer Ingelheim Venture FundEDBIAngelini Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Nuevocor raised?

Nuevocor has raised $45.0M in total funding. The most recent round was Series B. The last funding was announced in May 2025.

Who are Nuevocor's investors?

Nuevocor's investors include Highlight Capital, Kurma Partners, Boehringer Ingelheim Venture Fund, EDBI, Angelini Ventures.

Where is Nuevocor headquartered?

Nuevocor is headquartered in Singapore, Singapore.

What does Nuevocor do?

Nuevocor operates as a preclinical-stage biotech company.

What stage is Nuevocor at?

Nuevocor is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 6, 2025.

MLA

"Nuevocor — Funding & Investors." VCBacked, May 6, 2025, https://www.vcbacked.co/company/nuevocor. Accessed June 4, 2026.

APA

VCBacked. (2025). Nuevocor — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/nuevocor

Wikipedia (cite web)

{{cite web |title=Nuevocor — Funding & Investors |url=https://www.vcbacked.co/company/nuevocor |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 6, 2025.